Hiroko Ikenaga

5PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer cell biologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2026
12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy.

Hiroko Ikenaga, Ritsuzo Kozuka, Kirara Inoue

|Jul 12, 2025
The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma.

Anna Kakehashi, Shugo Suzuki, Yusaku Nishidoi

|Aug 29, 2024
Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment.

Hung Thai Vu, Vien Duc Nguyen, Hiroko Ikenaga

|Sep 28, 2022
Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms.

Truong Huu Hoang, Misako Sato-Matsubara, Hideto Yuasa

|Oct 25, 2021
Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment.

Hiroko Ikenaga, Sawako Uchida-Kobayashi, Akihiro Tamori

Pageof 1

Frequent Collaborators

3 joint publications

Tsutomu Matsubara

2 joint publications

Akihiro Tamori

1 joint publications

Sawako Uchida-Kobayashi

1 joint publications

Ritsuzo Kozuka